This inventor holds 1 USPTO granted patent and 1 EPO patent. Top assignees: Centre National De La Recherche Scientifique, Commissariat a L'energie Atomique Et Aux Energies Alternatives, Ipsen Pharma S.a.s.. Active years: 2016.
Company Filing History:
1 out of 5,383 
1 out of 8,816 
1 out of 108 
Years Active: 2016
Title: Innovator Spotlight: Maarten Ijsselstijn
Introduction
Maarten Ijsselstijn is an accomplished inventor based in Groningen, Netherlands. He holds a notable patent that contributes to the field of pharmacology, showcasing his dedication to innovative therapeutic solutions.
Latest Patents
Ijsselstijn's patent, titled "Octapeptide compounds derived from somatostatin and the therapeutic use thereof," introduces novel octapeptide compounds with a general formula of H-2-Nal-cyclo(Cys-Tyr-AA-Lys-Val-Cys)-Thr-NH. These compounds exhibit a strong affinity for specific somatostatin receptor subtypes, making them particularly beneficial for treating diseases associated with these receptors. Moreover, their favorable physiochemical properties allow them to be utilized in various formulations for medicaments, including pharmaceutical compositions that enhance therapeutic efficacy and versatility.
Career Highlights
Throughout his professional journey, Maarten Ijsselstijn has made significant contributions while working with reputable companies such as Ipsen Pharma S.a.s. and the Commissariat à l'énergie atomique. His expertise in pharmaceuticals and peptide research has solidified his reputation as an innovator in the industry.
Collaborations
Ijsselstijn has collaborated with esteemed colleagues, including Marie-Thérèse Paternostre and Jean-Christophe Cintrat. These partnerships emphasize the collaborative spirit of innovation, as they work together to harness their collective knowledge in the development of groundbreaking therapeutic solutions.
Conclusion
Maarten Ijsselstijn continues to be a pivotal figure in the realm of medicinal innovation with his contributions and patent in octapeptide compounds. His work not only showcases his inventiveness but also highlights the importance of collaboration and research in advancing therapeutic applications for a healthier future.